Michael Schirner
Nessuna posizione attualmente
Profilo
Dr. Michael Schirner, MD, is a Managing Director at mivenion GmbH.
Dr. Schirner was previously employed as a Principal by Schering AG.
He received his undergraduate degree from the Friedrich Schiller University of Jena and a doctorate degree from Martin-Luther-Universität Halle-Wittenberg.
Precedenti posizioni note di Michael Schirner
| Società | Posizione | Fine |
|---|---|---|
| Bayer Schering Pharma AG | Corporate Officer/Principal | 01/01/2007 |
mivenion GmbH
 mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Amministratore Delegato | - |
Formazione di Michael Schirner
| Friedrich Schiller University of Jena | Undergraduate Degree |
| Martin-Luther-Universität Halle-Wittenberg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| Bayer Schering Pharma AG | Health Technology |
mivenion GmbH
mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Michael Schirner
